Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06572410 · ClinicalTrials.gov registry record
Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision
A clinical trial of Tumors, Breast, sponsored by Elucent Medical.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06572410: Recruiting study of Tumors, Breast, sponsored by Elucent Medical.
NCT06572410 is a study of Tumors, Breast that is actively recruiting participants, run by Elucent Medical. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06572410, a study of Tumors, Breast, is actively recruiting participants, sponsored by Elucent Medical.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Observational study. The purpose of this study is to evaluate the use of real-time surgical navigation for the localization and surgical removal of soft tissue tumors. The goal is to collect information about the efficiency and effectiveness of the EnVisio Surgical Navigation for intraoperative guidance to obtain negative margin on initial specimen. Prospective Patient Study: 200 consecutive patients
Conditions Studied
Interventions
- DEVICE EnVisio Navigation System
Study Locations (1)
Florida
- Advent Winter Garden - Winter Garden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-08-07 |
| Est. Completion | 2026-02-15 |
What NCT06572410 shows while recruiting
NCT06572410 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Tumors, Breast appearing as the primary indexed condition, and to 1 intervention - of which EnVisio Navigation System is the first listed.
NCT06572410 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06572410 about?
NCT06572410 is a clinical study titled "Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision". Observational study. The purpose of this study is to evaluate the use of real-time surgical navigation for the localization and surgical removal of soft tissue tumors. The goal is to collect information about the efficiency and effectiveness of the EnVisio Surgical Navigation for intraoperative guid...
What is the current status of trial NCT06572410?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-08-07. Estimated completion is 2026-02-15.
What conditions does trial NCT06572410 study?
This clinical trial studies the following conditions: Tumors, Breast.
What interventions are being tested in trial NCT06572410?
The interventions under investigation include: EnVisio Navigation System (DEVICE).
Who is sponsoring clinical trial NCT06572410?
This trial is sponsored by Elucent Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06572410 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tumors, Breast
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI